MSH2 and prostate carcinoma: Most studies have been underpowered to observe differences by a specific mismatch repair gene, but there is more evidence of an increased risk of prostate cancer associated with pathogenic variants in MSH2 than the other genes.3, 5, 7, 8, 13, 14